Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide
Aperçu rapide pour Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide (ABIN8104193)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Fonction
- LGALS9 Peptide - middle region
-
Séquence
- YVVCNTRQNG SWGPEERKTH MPFQKGMPFD LCFLVQSSDF KVMVNGILFV
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-LGALS9 Antibody (ARP72264_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
-
Sujet
- The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.
-
Poids moléculaire
- 35kDa
-
ID gène
- 3965
-
UniProt
- O00182
Antigène
-